
About Kolmar BNH
Kolmar BNH is a publicly listed company based in Sejong City (South Korea) founded in 2004. It offers nutrition supplements and cosmetics. The company has 528 employees. Its chief executive, as recorded, is Jung Hwa Young. Its website kolmarbnh.co.kr draws about 32 thousand monthly visits. Its focus areas include Life Sciences, Nutraceuticals Tech, Supplements and Multicategory.
Company details
Kolmar BNH was established in 2004 in Sejong City, South Korea, within the health and cosmetics sector. Health foods, including supplements for immunity, sports nutrition, intestinal health, and gender-specific needs, are manufactured and distributed. Cosmetics are also produced alongside product development for diverse industries. Operations focus on nutritional and personal care solutions across domestic and potential international markets.
- Headquarters Sejong City, South Korea
- Employees 528
- Stage Public
- SectorsHealthcare
- Website category Finance · Financial Planning and Management
- Phoneβ’β’β’β’ β’β’β’β’
- Website kolmarbnh.co.kr
- Social Instagram YouTube
- Legal Name Kolmarbnh Co., Ltd.
- Annual Revenue$398.06 M (USD)-6.62as on Dec 31, 2025
- Net Profit-$15.7 M (USD)-225.58as on Dec 31, 2025
- EBITDA$31.98 M (USD)6.2as on Dec 31, 2025
- Employee Count528
Apps and channels of Kolmar BNH
its YouTube channel 콜마비앤에이치 has 17.8K subscribers and 30 videos.
Videos from Kolmar BNH
The most watched videos on Kolmar BNH's YouTube channel, 콜마비앤에이치 (17.8K subscribers). Click a video to play it here.
More on 콜마비앤에이치.
People of Kolmar BNH
1 people are tracked at Kolmar BNH (1 in leadership); the tracked headcount is 528.
| Name | Role | Group |
|---|---|---|
Jung Hwa Young | CEO | Leadership |
Complete people profiles for Kolmar BNH
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Kolmar BNH
Kolmar BNH is a publicly listed company on the KRX with ticker symbol 200130 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Jul 2014
- Listed onKRX: 200130
- Listed entityKolmarBNH Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7200130003
- Share price7,760.00 KRW (+0.26% on the day) · 2026-10-14
- Market capitalisation214,049,100,037.00 KRW
- Price to earnings20.0
- EPS (diluted, trailing year)-55.14 KRW
- Dividend yield0.78%
- Volume (last session)26,330
Financials of Kolmar BNH
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 574.88B KRW | -22.67B KRW | 46.18B KRW |
| 2024 | 615.64B KRW | 18.05B KRW | 43.49B KRW |
| 2023 | 579.55B KRW | 19.71B KRW | 46.36B KRW |
| 2022 | 575.90B KRW | 40.51B KRW | 75.53B KRW |
| 2021 | 593.08B KRW | 69.87B KRW | 103.11B KRW |
Detailed financial statements for Kolmar BNH
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Kolmar BNH
The website of Kolmar BNH (kolmarbnh.co.kr) receives about 31.8K visits a month and ranks #723,602 among all websites worldwide, #8,062 in Financial Planning and Management.
- Monthly visits31.8K
▲ 14.4% vs previous month
- Unique visitors6.7K
per month
- Global rank#723,602
among all websites
- Category rank#8,062
Finance · Financial Planning and Management
- Bounce rate21%
- Pages per visit6.2
- Average visit6 min 18 sec
- DevicesDesktop 54% Β· Mobile 46%
Websites whose visitors overlap most with Kolmar BNH. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dailyinvest.kr | 100% | #675,680 | View details | ||
dealsite.co.kr | dealsite.co.kr | 100% | #47,739 | β | |
| thebell.co.kr | 100% | 2.1M | #27,945 | View details | |
finance.daum.net | finance.daum.net | 60% | #15,246 | β | |
finance.naver.com | finance.naver.com | 60% | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kolmar Bnh
Complete news archive for Kolmar BNH
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kolmar BNH
Kolmar BNH was founded in 2004.
Kolmar BNH is headquartered in Sejong City, South Korea.
Jung Hwa Young is the CEO of Kolmar BNH, as recorded in our data.
Kolmar BNH has 528 employees.
Annual revenue of Kolmar BNH is $398.06M as on Dec 31, 2025.
Kolmar BNH was established in 2004 in Sejong City, South Korea, within the health and cosmetics sector. Health foods, including supplements for immunity, sports nutrition, intestinal health, and gender-specific needs, are manufactured and distributed. Cosmetics are also produced alongside product development for diverse industries. Operations focus on nutritional and personal care solutions across domestic and potential international markets.
Yes, Kolmar BNH is publicly traded on KRX under the ticker symbol 200130.
